| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Department of Oncology and Pathology [A. Zh., J. E., R. L., A. Ze.], Department of Medicine, Division of Hematology [C. Z., M. Ho., Z. Y., M. B., A. G., D. X., X. Y.], Department of Molecular Medicine [E. B., C. L., M. N.], and Microbiology & Tumor Biology Center [M. He.], Karolinska Hospital and Institutet, SE-171 76 Stockholm, Sweden
Activation of telomerase is a crucial step during cellular immortalization and malignant transformation of human cells and requires the induction of the catalytic component, human telomerase reverse transcriptase (hTERT), encoded by the hTERT gene. It is poorly understood how the hTERT gene is activated in human cancer cells. In the present study, we examined the hTERT gene copy number in human cancer cell lines and in primary tumor tissues. Amplification of the hTERT gene was observed in 8 of 26 (31%) tumor cell lines and 17 of 58 (30%) primary tumors examined (8 of 21 lung tumors, 3 of 10 cervical tumors, 5 of 19 breast carcinomas, and 1 of 8 neuroblastomas). In addition, 13 of 26 (50%) cell lines and 13 of 58 (22%) primary tumors displayed gain of hTERT gene copies with 34 copies/cell. The present findings imply that the hTERT locus may be a frequent target for amplification during tumorigenesis and that this genetic event probably contributes to the dysregulation of telomerase activity occurring in human tumors.
This article has been cited by other articles:
![]() |
Y.-J. Chen, H. G. Campbell, A. K. Wiles, M. R. Eccles, R. R. Reddel, A. W. Braithwaite, and J. A. Royds PAX8 Regulates Telomerase Reverse Transcriptase and Telomerase RNA Component in Glioma Cancer Res., July 15, 2008; 68(14): 5724 - 5732. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cao, L. I. Huschtscha, A. S. Nouwens, H. A. Pickett, A. A. Neumann, A. C-M. Chang, C. D. Toouli, T. M. Bryan, and R. R. Reddel Amplification of Telomerase Reverse Transcriptase Gene in Human Mammary Epithelial Cells with Limiting Telomerase RNA Expression Levels Cancer Res., May 1, 2008; 68(9): 3115 - 3123. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gil, P. Kerai, M. Lleonart, D. Bernard, J. C. Cigudosa, G. Peters, A. Carnero, and D. Beach Immortalization of Primary Human Prostate Epithelial Cells by c-Myc Cancer Res., March 15, 2005; 65(6): 2179 - 2185. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Dalerba, C. Guiducci, P. L. Poliani, I. Cifola, M. Parenza, M. Frattini, G. Gallino, I. Carnevali, I. Di Giulio, S. Andreola, et al. Reconstitution of Human Telomerase Reverse Transcriptase Expression Rescues Colorectal Carcinoma Cells from In vitro Senescence: Evidence against Immortality as a Constitutive Trait of Tumor Cells Cancer Res., March 15, 2005; 65(6): 2321 - 2329. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Horikawa and J. C. Barrett Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms Carcinogenesis, July 1, 2003; 24(7): 1167 - 1176. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Fan, Y. Wang, J. Kratz, D. J. Brat, Y. Robitaille, A. Moghrabi, E. J. Perlman, C. V. Dang, P. C. Burger, and C. G. Eberhart hTERT Gene Amplification and Increased mRNA Expression in Central Nervous System Embryonal Tumors Am. J. Pathol., June 1, 2003; 162(6): 1763 - 1769. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Stewart Multiple Levels of Telomerase Regulation Mol. Interv., December 1, 2002; 2(8): 481 - 483. [Abstract] [Full Text] |
||||
![]() |
J. Won, J. Yim, and T. K. Kim Sp1 and Sp3 Recruit Histone Deacetylase to Repress Transcription of Human Telomerase Reverse Transcriptase (hTERT) Promoter in Normal Human Somatic Cells J. Biol. Chem., October 4, 2002; 277(41): 38230 - 38238. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-S. Cong, W. E. Wright, and J. W. Shay Human Telomerase and Its Regulation Microbiol. Mol. Biol. Rev., September 1, 2002; 66(3): 407 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Mergny, J.-F. Riou, P. Mailliet, M.-P. Teulade-Fichou, and E. Gilson Natural and pharmacological regulation of telomerase Nucleic Acids Res., February 15, 2002; 30(4): 839 - 865. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Horikawa and J. C. Barrett cis-Activation of the Human Telomerase Gene (hTERT) by the Hepatitis B Virus Genome J Natl Cancer Inst, August 1, 2001; 93(15): 1171 - 1173. [Full Text] [PDF] |
||||
![]() |
K. S. J. Elenitoba-Johnson Complex Regulation of Telomerase Activity : Implications for Cancer Therapy Am. J. Pathol., August 1, 2001; 159(2): 405 - 410. [Full Text] |
||||
![]() |
J. Sachsinger, E. Gonzalez-Suarez, E. Samper, R. Heicappell, M. Muller, and Maria. A. Blasco Telomerase Inhibition in RenCa, a Murine Tumor Cell Line with Short Telomeres, by Overexpression of a Dominant Negative mTERT Mutant, Reveals Fundamental Differences in Telomerase Regulation between Human and Murine Cells Cancer Res., July 1, 2001; 61(14): 5580 - 5586. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Xu, N. Popov, M. Hou, Q. Wang, M. Bjorkholm, A. Gruber, A. R. Menkel, and M. Henriksson Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells PNAS, March 27, 2001; 98(7): 3826 - 3831. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |